期刊文献+

New prognostic markers in liver cirrhosis 被引量:2

New prognostic markers in liver cirrhosis
下载PDF
导出
摘要 Determining the prognosis of cirrhotic patients is not an easy task. Prognostic scores, like Child-Pugh and Model of End-stage Liver Disease scores, are commonly used by hepatologists, but do not always reflect superimposed events that may strongly influence the prognosis. Among them, bacterial intestinal translocation is a key phenomenon for the development of cirrhosis-related complications. Several biological variables(C-reactive protein, serum free cortisol, copeptin, von Willebrand factor antigen) are surrogates of "inflammatory stress" and have recently been identified as potential prognostic markers in cirrhotic patients. Most of these above mentioned markers were investigated in pilot studies with sometimes a modest sample size but allow us to catch a glimpse of the pathophysiological mechanisms leading to the worsening of cirrhosis. These new data should generate further well-designed studies to better assess the benefit for liver function of preventing intestinal bacterial translocation and microvascular thrombosis. The control of infection is vital and among all actors of immunity, vitamin D also appears to act as an anti-infective agent and therefore has probably a prognostic value. Determining the prognosis of cirrhotic patients is not aneasy task. Prognostic scores, like Child-Pugh and Modelof End-stage Liver Disease scores, are commonly usedby hepatologists, but do not always reflect superimposedevents that may strongly influence the prognosis.Among them, bacterial intestinal translocation is a keyphenomenon for the development of cirrhosis-relatedcomplications. Several biological variables (C-reactiveprotein, serum free cortisol, copeptin, von Willebrandfactor antigen) are surrogates of "inflammatory stress"and have recently been identified as potential prognosticmarkers in cirrhotic patients. Most of these abovementioned markers were investigated in pilot studieswith sometimes a modest sample size but allow us tocatch a glimpse of the pathophysiological mechanismsleading to the worsening of cirrhosis. These new datashould generate further well-designed studies to betterassess the benefit for liver function of preventingintestinal bacterial translocation and microvascularthrombosis. The control of infection is vital and amongall actors of immunity, vitamin D also appears to actas an anti-infective agent and therefore has probably aprognostic value.
出处 《World Journal of Hepatology》 CAS 2015年第9期1244-1250,共7页 世界肝病学杂志(英文版)(电子版)
关键词 CIRRHOSIS C-reactive protein COPEPTIN VITAMIN D SERUM free CORTISOL Von Willebrand factorantigen Cirrhosis C-reactive protein Copeptin Vitamin D Serum free cortisol Von Willebrand factor antigen
  • 相关文献

参考文献34

  • 1Levesque E, Hoti E, Azoulay D, Icha- P, Habouchi H, CastaingD, Samuel D, Saliba F. Prospective evaluation of the prognosticscores for cirrhotic patients admitted to an intensive care unit.J Hepatol 2012; 56: 95-102 [PMID: 21835136 DOI: 10.1016/j.jhep.2011.06.024].
  • 2Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL. Serum levelsof C-reactive protein and procalcitonin in critically ill patients withcirrhosis of the liver. J Lab Clin Med 2005; 146: 347-351 [PMID:16310518].
  • 3Park WB, Lee KD, Lee CS, Jang HC, Kim HB, Lee HS, Oh MD,Choe KW. Production of C-reactive protein in Escherichia coliinfectedpatients with liver dysfunction due to liver cirrhosis.Diagn Microbiol Infect Dis 2005; 51: 227-230 [PMID: 15808312].
  • 4Devaraj S, Kumaresan PR, Jialal I. C-reactive protein inducesrelease of both endothelial microparticles and circulating endothelialcells in vitro and in vivo: further evidence of endothelial dysfunction.Clin Chem 2011; 57: 1757-1761 [PMID: 21980169 DOI: 10.1373/clinchem.2011.169839].
  • 5Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C,Nguyen-Khac E, Duhamel C, Lebrec D, Poynard T, Moreau R.Model for end-stage liver disease score and systemic inflammatoryresponse are major prognostic factors in patients with cirrhosis andacute functional renal failure. Hepatology 2007; 46: 1872-1882[PMID: 17972337].
  • 6Cervoni JP, Thévenot T, Weil D, Muel E, Barbot O, Sheppard F,Monnet E, Di Martino V. C-reactive protein predicts short-termmortality in patients with cirrhosis. J Hepatol 2012; 56: 1299-1304[PMID: 22314431 DOI: 10.1016/j.jhep.2011.12.030].
  • 7Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J,Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, WendonJ, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M,Arroyo V. Acute-on-chronic liver failure is a distinct syndromethat develops in patients with acute decompensation of cirrhosis.Gastroenterology 2013; 144: 1426-1437, 1437.e1-9 [PMID:23474284 DOI: 10.1053/j.gastro.2013.02.042].
  • 8Cervoni JP, Amoros A, Moreau R, Arroyo V, Jalan R, Saliba F.Prognostic value of C-reactive protein in patients with cirrhosis:external validation from the CANONIC cohort. Hepatology 2014;60 (Suppl): 495A.
  • 9Thevenot T, Borot S, Remy-Martin A, Sapin R, Cervoni JP,Richou C, Vanlemmens C, Cleau D, Muel E, Minello A, TirziuS, Penfornis A, Di Martino V, Monnet E. Assessment of adrenalfunction in cirrhotic patients using concentration of serum-free andsalivary cortisol. Liver Int 2011; 31: 425-433 [PMID: 21281437DOI: 10.1111/j.1478-3231.2010.02431.x].
  • 10Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, ArltW, Keh D, Briegel J, Beishuizen A, Dimopoulou I, TsagarakisS, Singer M, Chrousos GP, Zaloga G, Bokhari F, VogeserM. Recommendations for the diagnosis and management ofcorticosteroid insufficiency in critically ill adult patients: consensusstatements from an international task force by the American Collegeof Critical Care Medicine. Crit Care Med 2008; 36: 1937-1949[PMID: 18496365 DOI: 10.1097/CCM.0b013e31817603ba].

同被引文献27

  • 1Yun-LinWu JingYe ShuZhang JieZhong Rong-PingXi.Clinical significance of serum IGF-I,IGF-II and IGFBP-3 in liver cirrhosis[J].World Journal of Gastroenterology,2004,10(18):2740-2743. 被引量:7
  • 2Patrick S. Kamath,Russell H. Wiesner,Michael Malinchoc,Walter Kremers,Terry M. Therneau,Catherine L. Kosberg,Gennaro D’Amico,E.Rolland Dickson,W.Ray Kim.A model to predict survival in patients with end-stage liver disease[J]. Hepatology . 2001 (2)
  • 3Richard Moreau,Rajiv Jalan,Pere Gines,Marco Pavesi,Paolo Angeli,Juan Cordoba,Francois Durand,Thierry Gustot,Faouzi Saliba,Marco Domenicali,Alexander Gerbes,Julia Wendon,Carlo Alessandria,Wim Laleman,Stefan Zeuzem,Jonel Trebicka,Mauro Bernardi,Vicente Arroyo.Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis[J].Gastroenterology.2013(7)
  • 4J. S.BAJAJ.Review article: the modern management of hepatic encephalopathy[J].Alimentary Pharmacology & Therapeutics.2010(5)
  • 5Emmanuel A Tsochatzis,Jaime Bosch,Andrew K Burroughs.Liver cirrhosis[J]. The Lancet . 2014
  • 6Bruce A. Runyon.??Management of adult patients with ascites due to cirrhosis: An update(J)Hepatology . 2009 (6)
  • 7Sanyal AJ,Brunt EM,Kleiner DE,Kowdley KV,Chalasani N,Lavine JE,Ratziu V,McCullough A.Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology . 2011
  • 8Jens-Gerd Scharf,Frank Schmitz,Jan Frystyk,Christian Skjaerbaek,Heidrun Moesus,Werner F. Blum,Giuliano Ramadori,Heinz Hartmann.??Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease(J)Journal of Hepatology . 1996 (5)
  • 9Rania Naguib Abdel Mouteleb Abdel Rehem,Wafaa Mohamed Hussein Mekky El-Shikh.Serum IGF-1, IGF-2 and IGFBP-3 as Parameters in the Assessment of Liver Dysfunction in Patients with Hepatic Cirrhosis and in the Diagnosis of Hepatocellular Carcinoma. Hepato Gastroenterology . 2011
  • 10Mohamed Shaarawy,Mohamed Amin Fikry,Baher Aly Massoud,Samar Lot.Insulin-Like Growth Factor Binding Protein-3: A Novel Biomarker for the Assessment of the Synthetic Capacity of Hepatocytes in Liver Cirrhosis. The Journal of Clinical Endocrinology . 1998

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部